AMRA Medical develops MRI-based body composition analysis for clinical care and research. Its standardized imaging protocol measures fat and muscle across participating imaging sites, providing data that researchers and clinicians can use to study disease mechanisms and treatment responses. The company’s MRI biomarkers support work in metabolic diseases and clinical trials in neuromuscular conditions.
Grow sales of AMRA Medical’s MRI-based health informatics platform by winning new customers, developing strategic accounts, and supporting expansion into new markets.